Syngenta Invests in U.S. Biotech Firm

Syngenta says its newly-established Syngenta Ventures corporate venture capital subsidiary, has made an equity investment in Metabolon (Durham, NC), a privately-held biotechnology company focused on the use of metabolomics in research and diagnostics. This is the first direct investment by Syngenta Ventures. Financial details of the equity investment in Metabolon were not disclosed. Metabolomics provides mechanistic insight and biochemical markers for complex biological processes, Syngenta says. This technology aims to accelerate the development of plants with...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers